Parallel Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

Parallel Advisors’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$28.7K	Sell
2025 Q1	$52K	Buy
2024 Q4	$76.6K	Buy
2024 Q3	$76.1K	Hold
2024 Q2	$66.7K	Sell
2024 Q1	$72.6K	Buy
2023 Q4	$15.6K	Buy
2022 Q4	–	Sell
2022 Q3	$0	Buy
2021 Q4	–	Sell
2021 Q3	$0	Buy